Skip to Content
Merck
CN
  • Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximes.

Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximes.

Bioorganic & medicinal chemistry letters (2005-02-03)
Xiaodong Xu, Todd Henninger, Darren Abbanat, Karen Bush, Barbara Foleno, Jamese Hilliard, Mark Macielag
ABSTRACT

Novel C6-carbamate ketolides with C2-fluorination and C9-oximation have been synthesized. The best compounds in this series displayed MIC values of 0.03-0.12 microg/mL against streptococci containing erm and mef resistance determinants and 2-4 microg/mL against Haemophilus influenzae. Several compounds also showed measurable activity against erm(B)-containing enterococci with MIC values of 2-8 microg/mL. In vivo activity was adversely affected by fluorination, possibly as a result of increased serum protein binding.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Erythromycin, meets USP testing specifications